A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/18299307

Download in:

View as

General Info

PMID
18299307